FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2145917992> ?p ?o ?g. }

• W2145917992 endingPage "12" @default.
• W2145917992 startingPage "3" @default.
• W2145917992 abstract ": To assess the efficacy and toxicity of involved field (IF) radiotherapy in conjunction with high-dose therapy (HDT) and autologous bone marrow transplantation (ABMT) in relapsed or refractory Hodgkin's disease (HD). : Between 1987 and 1994, 100 consecutive patients with relapsed or refractory HD were treated with high-dose carmustine, etoposide, and cyclophosphamide or fractionated total-body irradiation, high-dose etoposide, and cyclophosphamide before ABMT. In addition, 24 patients received IF radiotherapy as planned cytoreductive (n = 18) or consolidative (n = 6) therapy immediately before or following ABMT. : With a median follow-up of 40 months (range: 18–88 months), 3-year actuarial rates of freedom from relapse (FFR), survival (S), and event-free survival (EFS) were 66%, 64%, and 57%, respectively. Thirty-three patients (33%) relapsed at a median of 8 months after ABMT. Only 2 of 33 relapses (6%) occurred beyond 18 months. By multivariate analyses, factors associated with recurrence were pleural disease (p = 0.02), multiple pulmonary nodules (p = 0.03), and a poor response to cytoreductive therapy (p = 0.001). A median IF radiotherapy dose of 30 Gy (range: 12.5–45 Gy) was given to 67 sites in the 24 patients. Local failure occurred within four irradiated sites (6%) in two patients (8%). In patients with relapse Stage I–III disease (n = 62), the use of IF radiotherapy was associated with an improved 3-year FFR (100% vs. 67%, p = 0.04) and a trend toward improved S (85 vs. 60%, p = 0.16). Among patients not previously irradiated (n = 39), IF radiotherapy was associated with an improved FFR (85 vs. 57%, p = 0.07) and S (93 vs. 55%, p = 0.02). Crude rates of treatment-related Grade 5 complications (including late events and second malignancies) were similar with or without IF radiotherapy (17 vs. 14%). : In conjunction with high-dose therapy and autologous bone marrow transplantation, IF radiotherapy is well tolerated, effectively controls local and regional disease, and may improve survival in selected patients with relapsed or refractory Hodgkin's disease." @default.
• W2145917992 created "2016-06-24" @default.
• W2145917992 creator A5029655862 @default.
• W2145917992 creator A5055511966 @default.
• W2145917992 creator A5077236629 @default.
• W2145917992 date "1996-08-01" @default.
• W2145917992 modified "2023-10-02" @default.
• W2145917992 title "High-dose therapy and autologous bone marrow transplantation for relapsed/refractory hodgkin's disease: The impact of involved field radiotherapy on patterns of failure and survival" @default.
• W2145917992 cites W1527271915 @default.
• W2145917992 cites W1541287496 @default.
• W2145917992 cites W1768406053 @default.
• W2145917992 cites W1794717495 @default.
• W2145917992 cites W1828835859 @default.
• W2145917992 cites W1856398768 @default.
• W2145917992 cites W1888835857 @default.
• W2145917992 cites W1892398095 @default.
• W2145917992 cites W1922039121 @default.
• W2145917992 cites W1982405153 @default.
• W2145917992 cites W2006178875 @default.
• W2145917992 cites W2022776680 @default.
• W2145917992 cites W2044066622 @default.
• W2145917992 cites W2063580741 @default.
• W2145917992 cites W2065620512 @default.
• W2145917992 cites W2075898541 @default.
• W2145917992 cites W2091281353 @default.
• W2145917992 cites W2103525635 @default.
• W2145917992 cites W2143594378 @default.
• W2145917992 cites W2152309833 @default.
• W2145917992 cites W2170002821 @default.
• W2145917992 cites W2253580546 @default.
• W2145917992 cites W2254324119 @default.
• W2145917992 cites W2258178785 @default.
• W2145917992 cites W2273350722 @default.
• W2145917992 cites W2286687528 @default.
• W2145917992 cites W2496500655 @default.
• W2145917992 cites W4293241248 @default.
• W2145917992 cites W83964714 @default.
• W2145917992 cites W94237140 @default.
• W2145917992 doi "https://doi.org/10.1016/s0360-3016(96)00277-5" @default.
• W2145917992 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8823253" @default.
• W2145917992 hasPublicationYear "1996" @default.
• W2145917992 type Work @default.
• W2145917992 sameAs 2145917992 @default.
• W2145917992 citedByCount "97" @default.
• W2145917992 countsByYear W21459179922012 @default.
• W2145917992 countsByYear W21459179922013 @default.
• W2145917992 countsByYear W21459179922014 @default.
• W2145917992 countsByYear W21459179922015 @default.
• W2145917992 countsByYear W21459179922016 @default.
• W2145917992 countsByYear W21459179922017 @default.
• W2145917992 countsByYear W21459179922018 @default.
• W2145917992 countsByYear W21459179922019 @default.
• W2145917992 countsByYear W21459179922020 @default.
• W2145917992 countsByYear W21459179922021 @default.
• W2145917992 countsByYear W21459179922022 @default.
• W2145917992 countsByYear W21459179922023 @default.
• W2145917992 crossrefType "journal-article" @default.
• W2145917992 hasAuthorship W2145917992A5029655862 @default.
• W2145917992 hasAuthorship W2145917992A5055511966 @default.
• W2145917992 hasAuthorship W2145917992A5077236629 @default.
• W2145917992 hasBestOaLocation W21459179921 @default.
• W2145917992 hasConcept C121332964 @default.
• W2145917992 hasConcept C126322002 @default.
• W2145917992 hasConcept C141071460 @default.
• W2145917992 hasConcept C142424586 @default.
• W2145917992 hasConcept C143998085 @default.
• W2145917992 hasConcept C2776694085 @default.
• W2145917992 hasConcept C2776755627 @default.
• W2145917992 hasConcept C2778119113 @default.
• W2145917992 hasConcept C2778880498 @default.
• W2145917992 hasConcept C2780147359 @default.
• W2145917992 hasConcept C2911091166 @default.
• W2145917992 hasConcept C509974204 @default.
• W2145917992 hasConcept C71924100 @default.
• W2145917992 hasConcept C87355193 @default.
• W2145917992 hasConceptScore W2145917992C121332964 @default.
• W2145917992 hasConceptScore W2145917992C126322002 @default.
• W2145917992 hasConceptScore W2145917992C141071460 @default.
• W2145917992 hasConceptScore W2145917992C142424586 @default.
• W2145917992 hasConceptScore W2145917992C143998085 @default.
• W2145917992 hasConceptScore W2145917992C2776694085 @default.
• W2145917992 hasConceptScore W2145917992C2776755627 @default.
• W2145917992 hasConceptScore W2145917992C2778119113 @default.
• W2145917992 hasConceptScore W2145917992C2778880498 @default.
• W2145917992 hasConceptScore W2145917992C2780147359 @default.
• W2145917992 hasConceptScore W2145917992C2911091166 @default.
• W2145917992 hasConceptScore W2145917992C509974204 @default.
• W2145917992 hasConceptScore W2145917992C71924100 @default.
• W2145917992 hasConceptScore W2145917992C87355193 @default.
• W2145917992 hasIssue "1" @default.
• W2145917992 hasLocation W21459179921 @default.
• W2145917992 hasLocation W21459179922 @default.
• W2145917992 hasOpenAccess W2145917992 @default.
• W2145917992 hasPrimaryLocation W21459179921 @default.
• W2145917992 hasRelatedWork W11525018 @default.
• W2145917992 hasRelatedWork W2003345465 @default.
• W2145917992 hasRelatedWork W2019694656 @default.
• W2145917992 hasRelatedWork W2071060238 @default.

• next